KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EPS (Weighted Average and Diluted) (2016 - 2025)

Quest Diagnostics' EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $2.18 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 11.79% year-over-year to $2.18; the TTM value through Dec 2025 reached $8.75, up 13.78%, while the annual FY2025 figure was $8.75, 13.78% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $2.18 at Quest Diagnostics, up from $2.16 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $4.96 in Q2 2021 and bottomed at $0.92 in Q4 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is $2.04 (2023), against an average of $2.37.
  • The largest annual shift saw EPS (Weighted Average and Diluted) soared 373.97% in 2021 before it tumbled 70.7% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $3.14 in 2021, then crashed by 70.7% to $0.92 in 2022, then skyrocketed by 84.78% to $1.7 in 2023, then grew by 14.71% to $1.95 in 2024, then increased by 11.79% to $2.18 in 2025.
  • Per Business Quant, the three most recent readings for DGX's EPS (Weighted Average and Diluted) are $2.18 (Q4 2025), $2.16 (Q3 2025), and $2.47 (Q2 2025).